Companies/TW/4105

TTY BIOPHARM COMPANY LIMITED

Income flow

Annual
4105 ANNUAL Income StatementPeriod 2023-12-31Source ANNUAL
Net sales$6BRevenue$6BGross profit$3BCost of revenue$2BOperating profit$1BOperating expenses$2BNet profit$1BTax$244MOperating expenses$2B

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).5.60%5y avgAverage dividend yield over the past five years — a smoother view than the latest print.4.83%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).4.5PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.64.7%Shares outTotal shares currently outstanding (issued and not retired).248.6MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).191.7M
Dividend calendar
Ex-dividend
2026-03-26
Last cash
4.5 · 2026-03-26
Stock splits
  1. 1067:10002014-08-13